more importantly at the 4 month point 5 out of 6 showed progression free survival ? is that how you read it ?
in other words
50% of patients(3/6) had 30% reduction of tumour size that sustained for 2 months at the end of 4 months
another 30% or 2/6 Patients had a stable disease at the end of 4 months
so almost 80%+ had progression free disease ?
Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial, page-22
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.97M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 12.0¢ | $8.355K | 68.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20761 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 155906 | 2 |
View Market Depth
| Last trade - 15.44pm 29/08/2024 (20 minute delay) ? |
| ATX (ASX) Chart |